ACUTE ADRENAL FAILURE—ADRENAL CRISIS
Definition and Importance
- Acute adrenal failure (adrenal crisis) is an endocrine emergency, potentially fatal if untreated.
- Dominant features: Dehydration and cardiovascular collapse (shock).
Clinical Settings for Adrenal Crisis
- Known Primary Adrenal Insufficiency
- Omission of glucocorticoid therapy.
- Inadequate dose increase during physical stress (e.g., infection, surgery).
- Undiagnosed Primary Adrenal Insufficiency
- Undergoing major stress without prior recognition (acute infection, trauma, etc.).
- Necrosis of Adrenals
- Intra-adrenal hemorrhage/infarction.
- May be caused by infection, trauma, anticoagulant therapy, or coagulopathy.
- Secondary Adrenal Insufficiency (less common cause)
- Intact mineralocorticoid secretion usually prevents crisis, but severe stress or abrupt withdrawal of high-dose exogenous glucocorticoids can precipitate.
Adrenal Hemorrhage
- Consider in shock with infection, trauma, anticoagulation (heparin/warfarin), or coagulopathy (e.g., antiphospholipid syndrome).
- Possible back/flank/abdominal pain from intra-adrenal bleeding.
- Fulminant Meningococcemia: Hemorrhagic destruction of both adrenals → Waterhouse-Friderichsen syndrome (especially children/young adults).
- Presents with purpura, meningitis, shock, DIC, purpura fulminans.
Clinical Presentation
- Shock: Dehydration, hypotension (circulatory collapse).
- Additional Symptoms: Anorexia, nausea, vomiting, abdominal pain, fever, confusion, lethargy.
- Possible Preexisting Adrenal Failure signs: Hyperpigmentation, weight loss, hyponatremia, hyperkalemia.
- Misdiagnosis Risk: Fever + abdominal pain can mimic an acute surgical abdomen → potentially disastrous unnecessary surgery.
Empiric Treatment
- Consider in severely ill patients with shock refractory to fluids and pressors.
- Do not delay therapy for diagnostic test results if adrenal crisis is suspected.
Treatment for Adrenal Crisis
- Glucocorticoid Replacement
- Hydrocortisone sodium succinate: 100 mg IV bolus initially.
- Continue 100 mg IV q6–8h until resolution of precipitating illness, then taper.
- Volume Repletion
- Dextrose in isotonic saline (2–4 L over 4 hours), adjusted for comorbidities and response.
- Identify Underlying Cause
- Search for infection, hemorrhage, infarction, or other triggers.
- Monitoring
- Frequent checks of serum electrolytes, acid–base status, glucose, renal function.
CHRONIC ADRENAL INSUFFICIENCY
Rate and Extent of Adrenal Destruction
- >90% cortical destruction needed for overt clinical insufficiency.
- Slow Progression: May remain subclinical until precipitated by stress (infection, trauma, surgery).
Signs and Symptoms
- Both Glucocorticoid & Mineralocorticoid Deficiency (Primary Failure):
- Fatigue, generalized weakness, diffuse myalgias, arthralgias.
- Anorexia, weight loss, nausea, vomiting, abdominal pain.
- Psychiatric changes (irritability, depression, apathy).
- Postural hypotension, hyperpigmentation, salt craving.
- Hyponatremia, hyperkalemia, mild normocytic anemia.
- Hypoglycemia (more common in children).
- Hyperpigmentation:
- Increased ACTH → MSH effect.
- Darkening of friction areas (knees, knuckles, elbows), belt line, scars, inner lip surfaces, palmar creases, areola, freckles.
- Vitiligo (~20% of autoimmune Addison’s) from autoimmune destruction of melanocytes.
Gender-Specific
- Women: Loss of axillary & pubic hair, ↓libido due to low adrenal androgens.
- Men: Testicular androgens → minimal androgen deficiency signs.
Etiologies of Primary Adrenal Failure
- Autoimmune Adrenalitis (~80% in developed countries).
- Infections (tuberculosis historically; fungal, HIV).
- Metastatic Cancer (e.g., lung, breast, melanoma).
- Adrenal Hemorrhage (trauma, antiphospholipid syndrome).
- Adrenoleukodystrophy.
- Bilateral Adrenalectomy.
- Drug-Induced (mitotane, ketoconazole).
- Congenital (adrenal hypoplasia e.g., DAX1 or SF-1 mutations).
Autoimmune Associations
- 21-Hydroxylase Antibodies: Nearly universal in autoimmune Addison’s.
- Polyglandular Autoimmune Syndrome Type II (APS2):
- Addison’s + autoimmune thyroid disease + type 1 diabetes mellitus.
- More common in women, onset 20–40 years old.
- Polyglandular Autoimmune Syndrome Type I (APS1):
- Rare, autosomal recessive (AIRE gene mutations).
- Triad: Hypoparathyroidism, chronic mucocutaneous candidiasis, Addison’s.
LABORATORY FINDINGS AND TREATMENT OF PRIMARY ADRENAL INSUFFICIENCY
Lab Findings
- Low Cortisol, High ACTH.
- Hyponatremia, Hyperkalemia (loss of aldosterone).
- Mild metabolic acidosis, azotemia from volume depletion.
- Low DHEA-S, androstenedione → female loss of body hair.
- Cosyntropin Stimulation Test: No significant rise in cortisol.
Treatment Principles
- Glucocorticoid Replacement
- Hydrocortisone, cortisone acetate, or prednisone.
- Stress Dosing for major infections, surgery, trauma (2–3× usual dose).
- Mineralocorticoid Replacement
- Fludrocortisone (50–200 µg daily) to normalize serum K⁺, Na⁺, BP.
- Adjust dose by checking for hypokalemia, edema, or persistent hyperkalemia/hyponatremia.
- Patient Education
- Dose adjustments during illness, use of IM injection if vomiting.
- Medical identification (bracelet/card “adrenal insufficiency—give cortisone”).
- Keep emergency dexamethasone syringes for self-injection.
Perioperative Management
- Surgery with General Anesthesia: Stress dose coverage (e.g., methylprednisolone 20–40 mg IM pre-op, taper over 2–3 days).
- No Additional Mineralocorticoid typically needed until oral intake resumes.
LABORATORY FINDINGS AND TREATMENT OF SECONDARY ADRENAL INSUFFICIENCY
Key Distinctions from Primary
- No Hyperpigmentation: ACTH is low/normal (no MSH effect).
- Aldosterone Levels usually normal (RAAS intact) → minimal hyperkalemia or salt craving.
- Possible Hyponatremia: due to impaired free-water excretion, elevated vasopressin.
- May Present with pituitary/hypothalamic mass symptoms or other pituitary hormone deficits (e.g., hypothyroidism, hypogonadism).
Lab Findings
- Low Cortisol, Low/Undetectable ACTH → diagnosing certain if cortisol <5 µg/dL at 8 am with severely low ACTH.
- Cosyntropin Stimulation may show a delayed rise but peak <18 µg/dL.
Treatment
- Glucocorticoid Replacement
- No mineralocorticoid needed (aldosterone normal).
- Hydrocortisone or equivalent, often 2/3 AM, 1/3 PM dosing.
- Avoid Over- or Undertreatment
- Monitor clinical signs.
- Stress Dosing for severe illness or surgery.
- If Additional Pituitary Deficits: Manage hypothyroidism, hypogonadism, etc. after ensuring adequate cortisol replacement.